Luxembourg, N4·Biotechnology, Healthcare, Pharmaceuticals·Last fund filed 2025
Funds on file
2
Partners named
6
6 on a current fund
Recent board seats
1
last 24 months
Capital raised
—
across filed funds
What has 270 Healthcare Growth raised?
2 vehicles
Vehicle
Filed
Target
Sold to date
Investors
270 Healthcare Growth Fund I (LUX) SCSp-RAIFFiled to raise in 2025, with no closing reported yet.
2025
Indefinite
$0
0
270 Healthcare Growth Fund I LPFiled to raise in 2025, with no closing reported yet.
2025
Indefinite
$0
0
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at 270 Healthcare Growth can lead a round?
6 named
6 partners are named across this firm’s filings, 6 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Data & analytics1 · 4%
E-commerce & marketplaces1 · 4%
HR & future of work1 · 4%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of 270 Healthcare Growth’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a 270 Healthcare Growth partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
